Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study

OBJECTIVE: Switching from mepolizumab to benralizumab has been reported to significantly improve both asthma control and the lung function. However, the data on its efficacy in elderly patients with severe eosinophilic asthma are limited. This study aimed to assess whether elderly patients with seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Isoyama, Shoko, Ishikawa, Nobuhisa, Hamai, Kosuke, Matsumura, Mirai, Kobayashi, Hiroki, Nomura, Akio, Ueno, Sayaka, Tanimoto, Takuya, Maeda, Hiroyuki, Iwamoto, Hiroshi, Hattori, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259321/
https://www.ncbi.nlm.nih.gov/pubmed/35650114
http://dx.doi.org/10.2169/internalmedicine.8180-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259321/
https://www.ncbi.nlm.nih.gov/pubmed/35650114
http://dx.doi.org/10.2169/internalmedicine.8180-21

Ejemplares similares